Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
February 1, 2013
Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer
Manikanta Swamy Murahari, Mayur C Yergeri
Current Pharmaceutical Design
|
April 25, 2020
Current Developments in Targeted Drug Delivery Systems for Glioma
Dhrumi Patel, Sarika Wairkar, Mayur C Yergeri
Frontiers in Pharmacology
|
November 16, 2018
Tumor Microenvironment Targeted Nanotherapy
Clara Fernandes, Divya Suares, Mayur C Yergeri
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
October 31, 2012
Synthesis and in vitro cytotoxicity studies of certain novel heterocycles derived from bis 1, 2, 4-triazoles and their DNA damage studies
Madhusudan N Purohit, Chandrashekhar Venkaraddi Mangannavar, Mayur C Yergeri
Current Pharmaceutical Design
|
September 3, 2019
Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment
Maushmi S Kumar, Tanuja T Yadav, Rohan R Khair, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
February 2, 2021
Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular docking studies
Ercan Bursal, Fikret Turkan, Kenan Buldurun, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
April 16, 2015
Drug-DNA Interaction Studies of Acridone-Based Derivatives
Kuntebomanahalli Thimmaiah, Apoorva G Ugarkar, Elvis F Martis, et al.
Drug Development Research
|
May 27, 2024
Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study
Nilam Bhusare, Tanuja Yadav, Mukesh Nandave, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
February 1, 2013
Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer
Manikanta Swamy Murahari, Mayur C Yergeri
Current Pharmaceutical Design
|
April 25, 2020
Current Developments in Targeted Drug Delivery Systems for Glioma
Dhrumi Patel, Sarika Wairkar, Mayur C Yergeri
Frontiers in Pharmacology
|
November 16, 2018
Tumor Microenvironment Targeted Nanotherapy
Clara Fernandes, Divya Suares, Mayur C Yergeri
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
October 31, 2012
Synthesis and in vitro cytotoxicity studies of certain novel heterocycles derived from bis 1, 2, 4-triazoles and their DNA damage studies
Madhusudan N Purohit, Chandrashekhar Venkaraddi Mangannavar, Mayur C Yergeri
Current Pharmaceutical Design
|
September 3, 2019
Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment
Maushmi S Kumar, Tanuja T Yadav, Rohan R Khair, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
|
February 2, 2021
Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular docking studies
Ercan Bursal, Fikret Turkan, Kenan Buldurun, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
April 16, 2015
Drug-DNA Interaction Studies of Acridone-Based Derivatives
Kuntebomanahalli Thimmaiah, Apoorva G Ugarkar, Elvis F Martis, et al.
Drug Development Research
|
May 27, 2024
Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study
Nilam Bhusare, Tanuja Yadav, Mukesh Nandave, et al.
Page
of 1